FDA Press Releases
FDA Press Releases
The feed below is an automatic RSS feed from the FDA website.
- Statement from FDA Commissioner Marty Makary, M.D., M.P.H., on Florida Restriction of 7-OH Opioid Products
- FDA Commissioner Makary, USDA Secretary Rollins Celebrate Proposed Modernization of Orange Juice Regulations to Benefit American Growers
- A Statement from FDA Commissioner Marty Makary, M.D., M.P.H: Announcing Resolution of the IV Saline Solutions Shortage
- FDA Announces New FDA PreCheck Program to Boost U.S. Drug Manufacturing
- FDA Names Top HHS Lawyer as Chief Counsel
- FDA Requires Major Changes to Opioid Pain Medication Labeling to Emphasize Risks
- FDA Takes Steps to Restrict 7-OH Opioid Products Threatening American Consumers
- FDA Recommends Removal of Voluntary Hold for Elevidys for Ambulatory Patients
- FDA Investigating Death of 8-Year-Old Boy Who Received Elevidys
- HHS, FDA and USDA Address the Health Risks of Ultra-Processed Foods
- HHS, FDA Praise Consumer Brands Association’s Vow to Remove Artificial Colors from America’s Food Supply
- Stanford faculty member George Tidmarsh, M.D., Ph.D. named Director of Center for Drug Evaluation and Research
- FDA Requests Sarepta Therapeutics Suspend Distribution of Elevidys and Places Clinical Trials on Hold for Multiple Gene Therapy Products Following 3 Deaths
- FDA to Revoke 52 Obsolete Standards of Identity for Food Products
- FDA Issues Warning Letters to Firms Marketing Products Containing 7-Hydroxymitragynine